Skip to main content Skip to footer
Donate
South Dakota

South Dakota

State Facts

38

Deaths, or 43.2% of total overdose deaths involved opioids in 2024.¹

159,231

Claims, or 3.64% of all Medicare Part D claims were for opioids in 2022 – an average of 41 per prescriber.²

35.8

Opioid Prescriptions were written for every 100 persons in South Dakota in 2023.³

836

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$90,086,389.72
State Spending Recommendation

Enhance supports for alternative pain management strategies through expanded partnerships and awareness efforts.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

2025 Introduced Relevant Legislation

HB 1137

HB 1137 ensures that non-opioid pain treatments receive equal coverage to opioids under South Dakota’s Medicaid preferred drug list and private insurance formularies, preventing insurers from disadvantaging or restricting access to FDA-approved non-opioid pain medications.

Introduced
01/30/2025
Plan Impact
Medicaid & Commercial
Learn More

Voices Letters

HB 1137 Letter of Support

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf